Evaluate Bioequivalence of Burotam (1/1 g/Vial)

See also
Status	Clinical Trial	Phase
Completed	`NCT02763345` - The Added Value of a Mobile Application of Community Case Management on Pediatric Referral Rates in Malawi	N/A
Completed	`NCT00550706` - Drug Utilization Prevalence in a Pediatric Care Medical Center	N/A
Completed	`NCT01033799` - Effect of the Consumption of a Fermented Milk on Common Infections in Shift-workers	N/A
Completed	`NCT00761462` - BAY 0 9867 Cipro Pediatric Use Study (QUIP)	Phase 3
Completed	`NCT05088421` - A First in Human Study of the Safety and Tolerability of Single and Multiple Doses of BWC0977 in Healthy Volunteers	Phase 1
Completed	`NCT00828971` - A Study to Assess Efficacy and Safety of IV/PO Moxifloxacin in the Treatment of cSSSIs	Phase 3
Completed	`NCT05468723` - Evaluating Patient Comfort and Environmental Conditions in the Carecube Negative Pressure Isolation Chamber.1
Recruiting	`NCT02162966` - Safety and Efficacy Study of High Dose Colistin	Phase 4
Recruiting	`NCT00001281` - Studies of the Pathogenesis of HIV Infection in Human Peripheral Blood Cells and/or Body Fluids in People Living With and Without HIV
Active, not recruiting	`NCT02654210` - LoewenKIDS - Infections and the Development of the Immune System
Completed	`NCT02226263` - Severe Necrotizing Enterocolitis in Preterm Newborns <1500g Using Probiotics	Phase 2
Terminated	`NCT00211471` - Treatment of Rubeosis Iridis With Open-Label Anecortave Acetate Sterile Suspension ( 15 mg.).	Phase 2
Active, not recruiting	`NCT04342702` - A Study on the Prospective Cohort Library of COVID-19 in Southeran
Completed	`NCT02134548` - Sensitivity Study of Diagnostic for Detection of Chagas Infection	N/A
Active, not recruiting	`NCT01611025` - Hospital Microbial Ecology Follow the Introduction of Ertapenem and Other Newly Introduced Antibiotic Over Time	N/A
Completed	`NCT01361997` - Isopropyl Alcohol Against Chlorhexidine - Isopropyl Alcohol as Antiseptics to Prevent Hemoculture's Contamination	Phase 3
Completed	`NCT00638677` - Bifidobacterium Lactis BB12 and Xylitol Delivered With a Novel Slow-release Pacifier	Phase 4
Completed	`NCT02434848` - A Pilot Study Comparing the Immunogenicity of Fendrix vs. Double-dose Engerix B in HIV-infected Non-responders to Standard Hepatitis B Vaccination Courses	Phase 2/Phase 3
Completed	`NCT02544139` - Specificity Study of Diagnostic for Chagas Disease	N/A
Completed	`NCT00276198` - Efficacy Trial to Examine Efficacy of Multimicronutrient Home Supplementation in Infants	Phase 3

NCT number	NCT05654090
Study type	Interventional
Source	Yung Shin Pharm. Ind. Co., Ltd.
Contact
Status	Active, not recruiting
Phase	Phase 4
Start date	August 25, 2022
Completion date	February 20, 2023

Evaluate Bioequivalence of Burotam (1/1 g/Vial)

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms